Alcohol use disorder and associated factors among individuals with severe mental illnesses in Africa: a systematic review and meta-analysis.

Soc Psychiatry Psychiatr EpidemiolMar 6, 2026 (epub)
Clinical ResearchPsychiatryOpen access

Mulualem Kelebie, Getasew Kibralew, Gebresilassie Tadesse et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review and random-effects meta-analysis assessed alcohol use disorder (AUD) prevalence and associated factors among people with severe mental illness in Africa. It included 20 primary studies with 7,540 participants. The pooled AUD prevalence was 33.26% (95% CI: 26.41-40.12). AUD was significantly associated with male sex, younger age, current cigarette use, and a family history of alcohol use. The findings indicate a substantial burden of AUD in this population, although the reported associations do not establish that these factors cause AUD.

Key findings

  • Pooled AUD prevalence among people with severe mental illness in Africa was 33.26% (95% CI: 26.41-40.12).
  • Male sex was associated with AUD (OR = 3.45; 95% CI: 2.13-5.59).
  • Younger age, current cigarette use, and family history of alcohol use were associated with AUD (OR = 3.12, 4.80, and 3.25, respectively).

Why it matters

The pooled estimate suggests AUD is common among people with severe mental illness in the African studies reviewed. The associated factors may help services identify groups in whom assessment for alcohol-related problems is particularly relevant. Recognising co-occurring AUD is important because it adds to the clinical burden in a population already living with serious mental illness.

What to keep in mind

The review reports substantial heterogeneity among included studies and used a random-effects model. The associated factors are observational associations and cannot establish causation.

Source

Published in Soc Psychiatry Psychiatr Epidemiol. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Psychiatry

Clinical ResearchOncology (Medical)

Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.

DALY 2-EU was an open-label, multicentre, randomised phase 2 trial comparing tandem CD20-CD19-directed zamtocabtagene autoleucel (zamto-cel) with R-GemOx in adults with second-line relapsed or refractory large B-cell…

Lancet OncolOct 27, 2026Read summary
Clinical ResearchOncology (Medical)

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial.

UNION was a multicentre, open-label, randomised phase 3 trial at nine hospitals in China comparing neoadjuvant short-course radiotherapy followed by camrelizumab plus CAPOX with long-course chemoradiotherapy followed by…

Lancet OncolOct 25, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.